Systemic administration of morphine induced a hyperalgesic response in the hot plate test, at an extremely low dose (1–10 lg/kg). We have examined in vivo whether morphine, at an extremely low dose, induces acute central hypernociception following activation of the opioid receptor-mediated PLC/PKC inositol-lipid signaling pathway. The PLC inhibitor U73122 and the PKC blocker, calphostin C, dose dependently prevented the thermal hypernociception induced by morphine. This effect was also prevented by pretreatment with aODN against PLCb3 at 2 nmol/mouse and PKCc at 2–3 nmol/mouse. Low dose morphine hyperalgesia was dose dependently reversed by selective NMDA antagonist MK801 and ketamine. This study demonstrates the presence of a nociceptive PLCb3/PKCc/NMDA pathway stimulated by low concentrations of morphine, through lOR1 receptor, in mouse brain. This signaling pathway appears to play an opposing role in morphine analgesia. When mice were treated with a morphine analgesic dose (7 mg/kg), the downregulation of PLCb3 or PKCc at the same aODN doses used for the prevention of the hyperalgesic effect induced, respectively, a 46% and 67% potentiation in analgesic response. Experimental and clinical studies suggest that opioid may activate pronociceptive systems, leading to pain hypersensitivity and short-term tolerance, a phenomenon encountered in postoperative pain management by acute opioid administration. The clinical management of pain by morphine may be revisited in light of the identification of the signaling molecules of the hyperalgesic pathway.

Signaling pathway of morphine induced acute thermal hyperalgesia in mice / Nicoletta Galeotti; George B Stefano; Massimo Guarna; Enrica Bianchi; Carla Ghelardini. - In: PAIN. - ISSN 0304-3959. - STAMPA. - 123:(2006), pp. 294-305. [10.1016/j.pain.2006.03.008]

Signaling pathway of morphine induced acute thermal hyperalgesia in mice.

GALEOTTI, NICOLETTA;GHELARDINI, CARLA
2006

Abstract

Systemic administration of morphine induced a hyperalgesic response in the hot plate test, at an extremely low dose (1–10 lg/kg). We have examined in vivo whether morphine, at an extremely low dose, induces acute central hypernociception following activation of the opioid receptor-mediated PLC/PKC inositol-lipid signaling pathway. The PLC inhibitor U73122 and the PKC blocker, calphostin C, dose dependently prevented the thermal hypernociception induced by morphine. This effect was also prevented by pretreatment with aODN against PLCb3 at 2 nmol/mouse and PKCc at 2–3 nmol/mouse. Low dose morphine hyperalgesia was dose dependently reversed by selective NMDA antagonist MK801 and ketamine. This study demonstrates the presence of a nociceptive PLCb3/PKCc/NMDA pathway stimulated by low concentrations of morphine, through lOR1 receptor, in mouse brain. This signaling pathway appears to play an opposing role in morphine analgesia. When mice were treated with a morphine analgesic dose (7 mg/kg), the downregulation of PLCb3 or PKCc at the same aODN doses used for the prevention of the hyperalgesic effect induced, respectively, a 46% and 67% potentiation in analgesic response. Experimental and clinical studies suggest that opioid may activate pronociceptive systems, leading to pain hypersensitivity and short-term tolerance, a phenomenon encountered in postoperative pain management by acute opioid administration. The clinical management of pain by morphine may be revisited in light of the identification of the signaling molecules of the hyperalgesic pathway.
2006
123
294
305
Nicoletta Galeotti; George B Stefano; Massimo Guarna; Enrica Bianchi; Carla Ghelardini
File in questo prodotto:
File Dimensione Formato  
pain 2006.pdf

accesso aperto

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Open Access
Dimensione 631.18 kB
Formato Adobe PDF
631.18 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/326942
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 73
  • ???jsp.display-item.citation.isi??? 67
social impact